We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
MACACHA has designed natural protein shakes that have the nourishing power of plants, no artificial ingredients and have a positive impact on the environment, as well as looking beautiful on the kitchen counter!
days to go: Expired investment: £98,378
Cheran's Bakery, based in Kent, specializes in crafting sumptuous sweet treats available online and at their expanding chain of five stores. With sales exceeding £1.2 million since inception, they create indulgent and creatively packaged products, baked daily for maximum freshness and luxury. Their high-quality, visually appealing shop designs and 'Instagrammable' offerings have attracted over 24,000 social media followers, amplifying brand recognition, while their focus on delivering exceptional customer experiences fosters word-of-mouth promotion.
days to go: Expired investment: £325,482
TOAD is Oxford's first distillery, crafting gin, rye whiskey and vodka in bespoke stills using locally sourced populations of ancient heritage grain. Since launching in July 2017 they have achieved over £134k of revenue.
days to go: Expired investment: £868,100
Signature Brew strives to craft beer that enhances the musical experience. Since 2011, their mission has been to create more collaborative beers with bands and musicians than any other brand globally. Through the success of their flagship beers, Studio Lager and Roadie All-Night IPA, they aim to spread their vision of uniting people through exceptional beer, music, and memorable experiences on a national and international scale. Continuing their original objective of improving the beer scene at beloved venues and festivals, Signature Brew remains committed to this ethos. Their direct-to-consumer customer base is expanding across the UK, driven by partnerships with artists and venues within their community. Operating from their cutting-edge brewery in East London, which includes an iconic live music venue, they consistently produce award-winning beer while fervently supporting grassroots music.
days to go: Expired investment: £872,392
Having travelled in the Americas, our founder Ben wanted authentic Latin American meals back in the UK. So, with a market stall, £500, hard work and total focus, he developed quick cook Latin American sauces with the aim to enable busy people to easily cook tasty, healthy meals at home.
days to go: Expired investment: £222,790
The Saucy Affair Raw Sauces creates a new range of fresh, convenient, and healthy foods made of real ingredients. The company aims at relaunching 6 tried and tested products in retail, 3 dressings, and 3 sauces. The Saucy Affair Raw Sauces has targeted and engaged with 3 key revenue streams, that are: UK Retail & Wholesale, EU Food Service and Retail, and UK Food Service. With the proceeds, the company will employ an experienced team, implement its robust PR, Marketing, and Retail Activation Plan.
days to go: Expired investment: £130,724
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph